Stephen Motsko, Associate Vice President, Therapeutic Area Lead.  Center for Observational Research (CfOR) at Amgen.   

He joined Amgen in November 2020.  Prior, Stephen led the Pharmacopidemiology organization at Eli Lilly & Company for over a decade.  

He has published a number of peer-reviewed papers in the areas of observational research, drug safety and methods for comparative research.   

Stephen received his PhD in Pharmacoepidemiology/Health Outcome research & Doctor of Pharmacy (PharmD) degrees from the University of Texas at Austin.  

,